Two methods for the determination of urine density (relative density or specific mass) have been evaluated and compared using NCCLS protocols: the refractometric method and a new method based on the measure of shifts in harmonic oscillation (SHO). Within the range investigated (from 1,000 up to 1,034) the methods were linear. Total imprecision, including the carry-over, was the same for both: the 95% confidence limits, at the level of 1,003, 1,013 and 1,030, were 1,001-1,005, 1,011-1,015 and 1,028-1,032 respectively. In analysing urines having known density, the SHO method was always accurate, while the refractometric method was affected by a significant bias at protein and haemoglobin concentrations greater than 4 and 2 g/L respectively. A direct comparison of the results obtained by the two methods was made on 300 untimed specimens of urine with density ranging from 1,002 to 1,034; the equation of regression line (refractometric method on the x axis, SHO on the y axis), calculated with a non-parametric statistical method, was SHO = refractometric method + 0,001. Despite some urine specimens (24, i.e. 8%) showed density differences (absolute value) of more than 0,003 (between 0,004 and 0,007 relative density units), the good mean agreement observed allows to conclude that both methods give clinically useful analytical results.

Densitometry↗

PubMed1984

The endocrine pattern of late onset adrenal hyperplasia (21-hydroxylase deficiency).

We describe 5 adult women with severe hirsutism due to late onset 21-hydroxylase deficiency. Diagnosis was performed on the finding of high serum 17-hydroxyprogesterone (17OHP) levels with a marked hyperresponse to an ACTH test. The endocrine study showed in most patients a gonadotropin behavior similar to that observed in classical polycystic ovary (PCO) syndrome. Prolactin levels were slightly increased in basal conditions and presented an exaggerated response to TRH stimulation.

17-alpha-Hydroxyprogesterone↗

PubMed1984

Prolactin secretion in polycystic ovary syndrome (PCO): correlation with the steroid pattern.

To evaluate the prevalence of hyperprolactinaemia in PCO patients and its possible correlation with a steroid pattern, we studied prolactin secretion (basal and after TRH stimulation) in 40 women affected by typical PCO. LH, FSH, testosterone, oestradiol, oestrone, DHEA-s and 17-OHP serum levels were also evaluated. Twenty-one patients had prolactin (Prl) values in the normal range both in baseline conditions and after TRH stimulation; 10 patients had normal basal values of Prl but an exaggerated response to TRH stimulation; 9 patients had high Prl basal values and an exaggerated response to TRH. The presence of hyperprolactinaemia was associated with increased serum levels of oestrone (P less than 0.01), DHEA-s (P less than 0.01) and 17-OHP (P less than 0.05). In conclusion, hyperprolactinaemia is as relatively frequent condition which affects almost half the patients suffering from PCO and is probably related to an increase of serum oestrogens, mostly oestrone. Moreover, in patients with PCO and hyperprolactinaemia, the production of some other steroids is also affected.

17-alpha-Hydroxyprogesterone↗

PubMed1982

Kinetic-immunonephelometric determination of serum proteins in chronic liver diseases.

Explore the source record for details and available documents.

Blood Proteins↗